Symposium:
18. Antimicrobial Advances that Will Change Your Practice
Thursday, October 8, 2015: 8:30 AM-10:00 AM
Room: 6--AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the results of recent impactful studies in the anti-infective field
  • recognize how to apply the results of recent seminal studies to clinical practice
  • identify the limitations of recent antimicrobial therapeutic studies

Target Audience: Pharmacists, Members-in-training, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Healthcare workers, Fellows, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, Adult ID, Trainee

Moderators:  David Andes, MD, FIDSA, University of Wisconsin and Sujata M. Bhavnani, PharmD, MS, Institute for Clinical Pharmacodynamics (ICPD)

Presentations:
8:30 AM
39
Antibacterials: Gram-Positives
Helen W. Boucher, MD, FACP, FIDSA

9:00 AM
40
Gram-Negatives
Thomas Lodise, PharmD, PhD
9:30 AM
41
Antivirals
Janet a. Englund, MD, FIDSA, FPIDS

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-147-L01-P

Disclosures:

D. Andes, None

S. M. Bhavnani, Various: Research Contractor , Research support

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.